Stanton Matthew
- SEC CIK
- 0001814198
No open-market purchases or sales filed in the past year.
Current role at each company
- GBIO Generation Bio Co.CHIEF SCIENTIFIC OFFICERas of Jan 10, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Stanton Matthew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2021 (view filing) | Sep 14 | 2 days | Stanton MatthewCHIEF SCIENTIFIC OFFICER | SSale | −4.50K | $28.07 | −$126.3K | −2.2%198.2K after | |
| Sep 14, 2021 (view filing) | Sep 10 | 4 days | Stanton MatthewCHIEF SCIENTIFIC OFFICER | SSale | −3.00K | $25.97 | −$77.9K | −1.5%198.2K after | 2 lots |
| Aug 25, 2021 (view filing) | Aug 23 | 2 days | Stanton MatthewCHIEF SCIENTIFIC OFFICER | SSale | −1.50K | $25.04 | −$37.6K | −0.8%198.2K after | |
| Aug 11, 2021 (view filing) | Aug 10 | 1 day | Stanton MatthewCHIEF SCIENTIFIC OFFICER | SSale | −1.50K | $22.63 | −$33.9K | −0.8%198.2K after | 3 lots |
| Jul 14, 2021 (view filing) | Jul 12 | 2 days | Stanton MatthewCHIEF SCIENTIFIC OFFICER | SSale | −3.00K | $25.03 | −$75.1K | −1.5%198.2K after | 2 lots |